EX-24

LIMITED POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of Uneek Mehra and

Aaron Chan, signing singly, and with full power of substitution, the

undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity

as an officer, director, and/or securityholder of BridgeBio Oncology

Therapeutics, Inc., a Delaware corporation (the "Company"), from time to time

the following U.S. Securities and Exchange Commission ("SEC") forms: (i) Form 3,

Initial Statement of Beneficial Ownership of Securities, including any attached

documents; (ii) Form 4, Statement of Changes in Beneficial Ownership of

Securities, including any attached documents; (iii) Form 5, Annual Statement of

Beneficial Ownership of Securities in accordance with Section 16(a) of the

Securities Exchange Act of 1934, as amended, and the rules thereunder, including

any attached documents; (iv) Schedules 13D and 13G; and (v) amendments of each

thereof, in accordance with the Securities Exchange Act of 1934, as amended, and

the rules thereunder, including any attached documents;

(2) do and perform any and all acts for and on behalf of the undersigned which

may be necessary or desirable to complete and execute any such Form 3, 4 or 5,

Schedule 13D or 13G, or any amendment(s) thereto and timely file such form(s)

with the SEC and any securities exchange, national association or similar

authority; and

(3) take any other action of any type whatsoever in connection with the

foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,

in the best interest of, or legally required by, the undersigned, it being

understood that the documents executed by such attorney-in-fact on behalf of the

undersigned pursuant to this Power of Attorney shall be in such form and shall

contain such terms and conditions as such attorney-in-fact may approve in such

attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact, acting singly, full

power and authority to do and perform any and every act and thing whatsoever

requisite, necessary or proper to be done in the exercise of any of the rights

and powers herein granted, as fully to all intents and purposes as the

undersigned might or could do if personally present, with full power of

substitution or revocation, hereby ratifying and confirming all that such

attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall

lawfully do or cause to be done by virtue of this power of attorney and the

rights and powers herein granted. The undersigned acknowledges that the

foregoing attorneys-in-fact, in serving in such capacity at the request of the

undersigned, are not assuming, nor is the Company assuming, any of the

undersigned's responsibilities to comply with Section 16 or Regulation 13D-G of

the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees

to indemnify the attorneys-in-fact and the Company from and against any demand,

damage, loss, cost or expense arising from any false or misleading information

provided by the undersigned to the attorneys-in-fact.

This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file such forms with respect to the

undersigned's holdings of and transactions in securities issued by the Company,

unless earlier revoked by the undersigned in a signed writing delivered to the

foregoing attorneys-in-fact. This Power of Attorney supersedes any prior power

of attorney in connection with the undersigned's capacity as an officer and/or

director of the Company. This Power of Attorney shall expire as to any

individual attorney-in-fact if such attorney-in-fact ceases to be an employee of

the Company.